OpenLB
Open Library of Bioscience
Advanced Search
Cancers
Sep 15, 2023;15 (18):

Protective Factors against Fear of Cancer Recurrence in Breast Cancer Patients: A Latent Growth Model.

Gabriella Bentley, Osnat Zamir, Rawan Dahabre, Shlomit Perry, Evangelos C Karademas, Paula Poikonen-Saksela, Ketti Mazzocco, Berta Sousa, Ruth Pat-Horenczyk, BOUNCE Consortium
Author Information
  1. Gabriella Bentley: School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel. ORCID
  2. Osnat Zamir: School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.
  3. Rawan Dahabre: School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel.
  4. Shlomit Perry: School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel. ORCID
  5. Evangelos C Karademas: Department of Psychology, University of Crete and Foundation for Research and Technology, 70013 Heraklion, Greece.
  6. Paula Poikonen-Saksela: Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, 00100 Helsinki, Finland.
  7. Ketti Mazzocco: Department of Oncology and Hemato-Oncology, University of Milan, 20139 Milan, Italy. ORCID
  8. Berta Sousa: Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, 1400-038 Lisboa, Portugal. ORCID
  9. Ruth Pat-Horenczyk: School of Social Work and Social Welfare, Hebrew University of Jerusalem, Jerusalem 9190500, Israel. ORCID
PMID: 37760558 DOI: 10.3390/cancers15184590

Abstract

The current study aimed to examine the fear of cancer recurrence (FCR) trajectory and protective predictors in women coping with breast cancer (BC). The study's model investigated whether a higher coping self-efficacy and positive cognitive-emotion regulation at the time of the BC diagnosis would lead to reduced levels of FCR at six months and in later stages (12 and 18 months) post-diagnosis. The sample included 494 women with stages I to III BC from Finland, Italy, Portugal, and Israel. They completed self-report questionnaires, including the Fear of Cancer Recurrence Inventory (FCRI-SF), the Cancer Behavior Inventory-Brief Version (CBI-B), the Cognitive-Emotion Regulation Questionnaire (CERQ short), and medical-social-demographic data. Findings revealed that a higher coping self-efficacy at diagnosis predicted lower FCR levels after six months but did not impact the FCR trajectory over time. Surprisingly, positive cognitive-emotion regulation did not predict FCR levels or changes over 18 months. FCR levels remained stable from six to 18 months post-diagnosis. This study emphasizes the importance of developing specific cancer coping skills, such as coping self-efficacy. Enhancing coping self-efficacy in the first six months after BC diagnosis may lead to lower FCR levels later, as FCR tends to persist in the following year.

Keywords

BOUNCE breast cancer coping self-efficacy fear of cancer recurrence latent growth modeling trajectories

References

  1. Psychooncology. 2022 Jun;31(6):879-892 [PMID: 35388525]
  2. Oncol Nurs Forum. 2012 May 1;39(3):287-95 [PMID: 22543387]
  3. J Cancer Surviv. 2015 Mar;9(1):68-79 [PMID: 25135205]
  4. Psychooncology. 2007 Mar;16(3):171-80 [PMID: 16858670]
  5. J Transcult Nurs. 2019 Mar;30(2):146-153 [PMID: 29708040]
  6. Psychooncology. 2007 Apr;16(4):329-41 [PMID: 16888704]
  7. Psychooncology. 2021 Sep;30(9):1555-1562 [PMID: 33998100]
  8. Support Care Cancer. 2016 Oct;24(10):4207-18 [PMID: 27169700]
  9. Cancer Res Treat. 2022 Oct;54(4):1065-1073 [PMID: 34883553]
  10. Singapore Med J. 2021 Jun;62(6):305-310 [PMID: 31989183]
  11. Clin Psychol Rev. 2019 Mar;68:13-24 [PMID: 30617013]
  12. J Psychosom Res. 2023 Mar;166:111177 [PMID: 36739729]
  13. BMC Cancer. 2018 Oct 20;18(1):1002 [PMID: 30342495]
  14. Int J Environ Res Public Health. 2022 Sep 30;19(19): [PMID: 36231811]
  15. Psychotherapy (Chic). 2022 Jun;59(2):261-270 [PMID: 34990161]
  16. Sci Rep. 2014 Jul 04;4:5569 [PMID: 24993798]
  17. Cancer J. 2008 Nov-Dec;14(6):369-74 [PMID: 19060601]
  18. Front Psychol. 2020 Nov 02;11:580979 [PMID: 33224072]
  19. Front Psychol. 2021 Jun 09;12:647432 [PMID: 34177701]
  20. Eur J Cancer Care (Engl). 2008 Mar;17(2):157-66 [PMID: 18302653]
  21. Psychol Health. 2019 Jan;34(1):44-63 [PMID: 30516396]
  22. Front Psychiatry. 2022 Jun 16;13:859604 [PMID: 35782420]
  23. J Natl Cancer Inst. 2021 Nov 2;113(11):1495-1505 [PMID: 34057469]
  24. Acta Oncol. 2017 Feb;56(2):314-320 [PMID: 28093034]
  25. Support Care Cancer. 2022 Mar;30(3):2829-2837 [PMID: 34845503]
  26. Psychooncology. 2013 May;22(5):978-86 [PMID: 22674873]
  27. Am Psychol. 1989 Mar;44(3):513-24 [PMID: 2648906]
  28. Support Care Cancer. 2014 Mar;22(3):705-12 [PMID: 24193220]
  29. J Psychosoc Oncol. 2020 Mar-Apr;38(2):156-170 [PMID: 31625826]
  30. Psychooncology. 1997 Jun;6(2):95-105 [PMID: 9205967]
  31. Cancer Nurs. 2022 Sep-Oct 01;45(5):406-415 [PMID: 34560707]
  32. Psychooncology. 2013 Jan;22(1):1-11 [PMID: 22232030]
  33. Oncotarget. 2017 May 30;8(22):36800-36811 [PMID: 28404938]
  34. Eur J Cancer Care (Engl). 2019 Sep;28(5):e13113 [PMID: 31180170]
  35. Cancer Med. 2018 Oct;7(10):4980-4992 [PMID: 30187678]
  36. Psychooncology. 2011 Mar;20(3):302-12 [PMID: 20878830]
  37. Clin J Oncol Nurs. 2016 Dec 1;20(6):E155-E161 [PMID: 27857253]
  38. J Sch Psychol. 2010 Feb;48(1):5-37 [PMID: 20006986]
  39. J Psychosom Res. 2013 Apr;74(4):354-60 [PMID: 23497839]
  40. J Clin Oncol. 2009 Dec 20;27(36):6172-9 [PMID: 19884548]
  41. Psychooncology. 2018 Jan;27(1):295-301 [PMID: 28727897]
  42. Psychooncology. 2019 Oct;28(10):2033-2041 [PMID: 31364222]
  43. Cancer. 2022 Jan 15;128(2):335-343 [PMID: 34614212]
  44. J Cancer Surviv. 2013 Sep;7(3):300-22 [PMID: 23475398]
  45. Psychooncology. 2017 Oct;26(10):1444-1454 [PMID: 27246348]
  46. Integr Cancer Ther. 2016 Jun;15(2):175-82 [PMID: 26420778]
  47. Health Psychol. 2016 Jan;35(1):1-9 [PMID: 26030308]
  48. Clin Breast Cancer. 2019 Jun;19(3):165-177 [PMID: 30952546]
  49. Psychol Assess. 2018 Apr;30(4):486-499 [PMID: 28504538]
  50. Support Care Cancer. 2016 Aug;24(8):3265-8 [PMID: 27169703]
  51. Gynecol Oncol. 2007 Feb;104(2):381-9 [PMID: 17027072]
  52. Am J Transl Res. 2022 Jul 15;14(7):4804-4811 [PMID: 35958474]
  53. BMC Cancer. 2022 Apr 15;22(1):414 [PMID: 35428224]
  54. Health Psychol. 2016 Dec;35(12):1329-1333 [PMID: 27175578]
  55. Breast Care (Basel). 2019 Dec;14(6):344-353 [PMID: 31933579]
  56. J Pain Symptom Manage. 2020 Aug;60(2):381-389 [PMID: 32105790]
  57. Sch Inq Nurs Pract. 2001 Fall;15(3):277-94 [PMID: 11871585]
  58. Psychooncology. 2020 Nov;29(11):1835-1841 [PMID: 32720375]
  59. Psychooncology. 2009 Jan;18(1):71-8 [PMID: 18613299]
  60. Body Image. 2018 Dec;27:21-31 [PMID: 30121489]
  61. Psychooncology. 2012 Feb;21(2):203-10 [PMID: 22271541]
  62. Psychooncology. 2019 Sep;28(9):1781-1790 [PMID: 31206917]
  63. Support Care Cancer. 2009 Mar;17(3):241-51 [PMID: 18414902]
  64. Support Care Cancer. 2015 Jul;23(7):2033-43 [PMID: 25524004]

Grants

  1. 777167/European Union's Horizon 2020 Research and Innovation Programme
  2. /Canadian Friends of the Hebrew University (CFHU) Fellowship Fund
Journal Article
Article has an altmetric score of 13

Word Cloud

Created with Highcharts 10.0.0FCRcopingmonthscancerself-efficacylevelsBCsixCancerdiagnosis18studyfearrecurrencetrajectorywomenbreasthigherpositivecognitive-emotionregulationtimeleadlaterstagespost-diagnosisFearRecurrencelowercurrentaimedexamineprotectivepredictorsstudy'smodelinvestigatedwhetherreduced12sampleincluded494IIIFinlandItalyPortugalIsraelcompletedself-reportquestionnairesincludingInventoryFCRI-SFBehaviorInventory-BriefVersionCBI-BCognitive-EmotionRegulationQuestionnaireCERQshortmedical-social-demographicdataFindingsrevealedpredictedimpactSurprisinglypredictchangesremainedstableemphasizesimportancedevelopingspecificskillsEnhancingfirstmaytendspersistfollowingyearProtectiveFactorsBreastPatients:LatentGrowthModelBOUNCElatentgrowthmodelingtrajectories

Similar Articles

Cited By